RNS Number : 0535A
Barclays PLC
13 February 2014
 



 

13 February 2014 

Barclays PLC

("the Company")

 

Director/PDMR shareholding: Disclosure and Transparency Rules 3.1.4R (1) (a)

 

On 12 February 2014 the following ordinary shares in Barclays PLC ("the Company") were purchased on the London Stock Exchange on behalf of the Chairman and the non-executive Directors of the Company.  These purchases arise from the policy of using part of the fee payable to each Director to purchase shares in the Company, which, together with any reinvested dividends, are retained for the Director until they leave the Board.

 

DIRECTOR

 

BARCLAYS PLC SHARES PURCHASED

PRICE PER SHARE

TOTAL BENEFICIAL INTEREST FOLLOWING THIS NOTIFICATION

 

TOTAL NON-BENEFICIAL INTEREST FOLLOWING THIS NOTIFICATION

Mike Ashley

2,937

£2.620672

13,986

-

Tim Breedon

3,058

£2.620672

9,737

-

Fulvio Conti

3,752

£2.620672

84,586

-

Diane de Saint Victor

3,526

£2.620672

8,473

-

Simon Fraser

3,297

£2.620672

120,041

-

Reuben Jeffery¹

4,548

£2.620672

170,370

-

Wendy Lucas-Bull

2,793

£2.620672

4,793

-

Dambisa Moyo

3,298

£2.620672

31,112

-

Sir Michael Rake

3,404

£2.620672

63,960

-

Sir John Sunderland

3,438

£2.620672

130,435

-

Frits van Paasschen²

3,847

£2.620672

6,355

-

Sir David Walker

9,591

£2.620672

124,992

-

 

 

 ¹ Reuben Jeffery's beneficial interest comprises 31,358 American Depositary Shares and 44,938 Ordinary Shares in Barclays PLC

 

 

² Frits van Paasschen's beneficial interest comprises 627 American Depositary Shares and 3,847 Ordinary Shares in Barclays PLC

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGUQGPUPCGQW